International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing-Reference-Cited by-同舟云学术

International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing

Published:2019-06 Issue:4 Volume:29 Page:76-83
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Pereira Naveen L.,So Derek,Bae Jang-Ho,Chavez Ivan,Jeong Myung Ho,Kim Sang Wook,Madan Mina,Graham John,O’Cochlain Fearghas,Pauley Nicole,Lennon Ryan J.,Bailey Kent,Hasan Ahmed,Baudhuin Linnea M.,Bell Malcolm R.,Lerman Amir,Goodman Shaun,Mathew Verghese,Farkouh Michael,Rihal Charanjit S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference26 articles.

1. Cardiovascular pharmacogenomics and individualized drug therapy;Pereira;Nat Rev Cardiol,2009

2. Genotype-based clinical trials in cardiovascular disease;Pereira;Nat Rev Cardiol,2015

3. Genetic determinants of response to clopidogrel and cardiovascular events;Simon;N Engl J Med,2009

4. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

5. Cytochrome P-450 polymorphisms and response to clopidogrel;Mega;N Engl J Med,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

2. Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update;Journal of NeuroInterventional Surgery;2023-05-15

3. Genetic-Guided Oral P2Y12 Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2023-04

4. An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinic;Genetics in Medicine;2023-03

5. Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors;Genes;2023-02-25